Literature DB >> 22198895

[Prevalence and risk factors of thromboembolic complications in inflammatory bowel disease].

Yosra Said1, Lamine Hamzaoui, Kaouther El Jeri, Radhouane Debbeche, Senda Trabelsi, Amel Moussa, Slim Bouzaidi, Mohammed Salem, Sami Guermazi, Taoufik Najjar.   

Abstract

BACKGROUND: Patients with inflammatory bowel disease (IBD) are at increased risk of thromboembolic complications (TEC), which represent an important cause of morbidity and mortality. AIM: To assess the prevalence and risk factors of TEC in patients with IBD.
METHODS: We conducted a retrospective study including all the IBD patients in the gastroenterological department of Charles Nicolle hospital between 2000 and 2010. Only thromboembolic events that had been diagnosed by an imaging procedure were counted.
RESULTS: A total of 266 patients with IBD were consecutively included. TE events occurred in nine patients (3.4%); six men and three women. Their mean age was 31 years [15-64 years]. Five patients had Crohn's disease and four had ulcerative colitis. The types of TEC were deep venous thrombosis of the leg in five cases with pulmonary embolism in one of them, cerebral venous thrombosis in two cases, portal thrombosis in one case and jugular vein thrombosis in one case. Active disease was present in all cases at the time TEC occurred.
CONCLUSIONS: In our study, the prevalence of TEC is 3.4% in patients with IBD. Deep venous thromboses of the leg are the most common TEC and all our cases occurs during the active phase of IBD.

Entities:  

Mesh:

Year:  2011        PMID: 22198895

Source DB:  PubMed          Journal:  Tunis Med        ISSN: 0041-4131


  3 in total

1.  Levels of TAFI, TFPI and ADAMTS-13 in inflammatory bowel disease.

Authors:  Bilgehan Yüzbaşıoğlu; Müge Ustaoğlu; Şule Yüzbaşıoğlu; Ulaş Emre Akbulut; Kamil Özdil
Journal:  Turk J Gastroenterol       Date:  2019-12       Impact factor: 1.852

2.  Portal venous thrombosis after distal pancreatectomy: clinical outcomes.

Authors:  Ashwin S Kamath; Michael G Sarr; David M Nagorney; Robert D McBane; Michael B Farnell; Kaye M Reid Lombardo; Florencia G Que; John H Donohue; Michael L Kendrick
Journal:  J Gastrointest Surg       Date:  2014-02-20       Impact factor: 3.452

3.  Thromboembolic events in patients with inflammatory bowel disease.

Authors:  Farjah H Algahtani; Youssef M K Farag; Abdulrahman M Aljebreen; Nahla A Alazzam; Aamer S Aleem; Fouad F Jabri; Mohammad H Rajab; Mohamed M Shoukri
Journal:  Saudi J Gastroenterol       Date:  2016-11       Impact factor: 2.485

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.